May 14, 2026
Kisspeptin GPR54 Research: Neuroendocrine Pathways
Explore Kisspeptin GPR54 research: KISS1 signaling, GnRH neuron activation, LH/FSH pulses, and hypothalamic neuroendocrine findings in preclinical models.
RESEARCH NOTES
May 14, 2026
Explore Kisspeptin GPR54 research: KISS1 signaling, GnRH neuron activation, LH/FSH pulses, and hypothalamic neuroendocrine findings in preclinical models.
May 14, 2026
Preclinical research on Dihexa nootropic peptide covers HGF/c-Met agonism, hippocampal synaptogenesis, and spatial memory findings by McCoy, Wright & Harding.
May 14, 2026
Preclinical research on LL-37 cathelicidin peptide covers membrane disruption, immunomodulation, wound healing, and anti-biofilm activity in lab models.
May 14, 2026
Explore SS-31 Elamipretide mitochondrial cardiolipin research: electron transport chain data, ROS reduction, cardiac and renal preclinical model findings.
May 14, 2026
Explore preclinical research on the Humanin mitochondrial peptide: neuroprotection, BAX inhibition, STAT3 signaling, and comparisons with MOTS-c and SS-31.
May 14, 2026
Review preclinical data on DSIP delta sleep peptide: EEG delta wave promotion, circadian entrainment, stress modulation, and antioxidant findings in rodents.
May 14, 2026
Research on PT-141 Bremelanotide melanocortin MC4R receptor binding, CNS signalling, and preclinical rodent model findings reviewed by specialist researchers.
May 14, 2026
Explore preclinical research on AOD-9604 GH fragment: lipolytic mechanisms, adipogenesis inhibition, β3-adrenergic signalling, and safety data in rodent models.
May 14, 2026
Explore preclinical Thymosin Alpha-1 immune research: T-cell maturation, TLR signalling, NK activity, antiviral and antitumour findings in animal models.
May 14, 2026
Explore Hexarelin peptide research — GHSR-1a agonism, CD36 cardiac binding, GH pulse amplitude, and cardioprotection data from preclinical animal models.